SynthesisInternational journal of colorectal disease2019

An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease.

Mahmoud Ahmed Ebada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.